TransCode Therapeutics Inc.(RNAZ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RNAZ TransCode Therapeutics Inc.

未开盘 11-06 16:00:00 EST

1.49

-0.02

-1.32%

盘后1.49

+0.000.00%

19:42 EST

最高1.56	最低1.45	成交量1.28万
今开1.53	昨收1.51	日振幅7.28%
总市值2,523万	流通市值320.83万	总股本1,693万
成交额1.95万	换手率0.59%	流通股本215.32万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RNAZ","market":"US","secType":"STK","nameCN":"TransCode Therapeutics  Inc.","latestPrice":1.49,"timestamp":1793998800000,"preClose":1.51,"halted":0,"volume":12788,"hourTrading":{"tag":"盘后","latestPrice":1.49,"preClose":1.49,"latestTime":"19:42 EST","volume":59,"amount":89.9285,"timestamp":1794012152451,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.013245033112582794,"floatShares":2153200,"shares":16930739,"eps":-50.6904,"marketStatus":"未开盘","change":-0.02,"latestTime":"11-06 16:00:00 EST","open":1.53,"high":1.56,"low":1.45,"amount":19476.7531696,"amplitude":0.072848,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-50.6904,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":0,"adr":0,"listingDate":1622520000000,"exchange":"NASDAQ","adjPreClose":1.51,"preHourTrading":{"tag":"盘前","latestPrice":1.51,"preClose":1.51,"latestTime":"04:39 EST","volume":2,"amount":3.02,"timestamp":1793957952929,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.49,"preClose":1.49,"latestTime":"19:42 EST","volume":59,"amount":89.9285,"timestamp":1794012152451,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.701339854284176},"requestUrl":"/m/hq/s/RNAZ","defaultTab":"news","newsList":[{"id":"1147853828","title":"TransCode Therapeutics 即刻任命 John Tattory 为临时首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1147853828","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147853828?lang=zh_cn&edition=full","pubTime":"2026-09-11 04:11","pubTimestamp":1789071069,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics 宣布，John Tattory 已即刻就任临时首席财务官一职。该人事任命立即生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129953342","title":"TransCode公司TTX-MC138进入ctDNA阳性结直肠癌IIa期临床开发阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1129953342","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129953342?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:05","pubTimestamp":1780488323,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics公司的在研疗法TTX-MC138，在针对循环肿瘤DNA（ctDNA）阳性结直肠癌的临床研究中取得重要进展，现已推进至IIa期开发阶段。这一进展标志着该疗法在探索性治疗领域迈出了关键一步，旨在为特定患者群体提供新的潜在治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNAZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157496823","title":"TransCode Therapeutics启动针对ctDNA阳性结直肠癌患者的TTX-MC138二期a临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1157496823","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157496823?lang=zh_cn&edition=full","pubTime":"2026-05-27 20:06","pubTimestamp":1779883565,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics公司已启动一项二期a阶段临床试验，该试验旨在评估其候选药物TTX-MC138在循环肿瘤DNA（ctDNA）阳性的结直肠癌患者中的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518275610","title":"Transcode Therapeutics, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518275610?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613493,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Transcode Therapeutics, Inc.股票出现波动，股价快速拉升5.10%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1825.42%、384.06%、45.95%，振幅较大的相关个股有Xencor, Inc.、Seer, Inc.、Y-Mabs Therapeutics, Inc.，振幅分别为99.13%、98.72%、94.67%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213133964035b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213133964035b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516823632","title":"Transcode Therapeutics, Inc.盘中异动 早盘快速跳水5.05%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516823632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516823632?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:34","pubTimestamp":1741012489,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时34分，Transcode Therapeutics, Inc.股票出现异动，股价快速跳水5.05%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.12%、30.13%、28.75%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Pliant Therapeutics, Inc.，振幅分别为21.22%、19.25%、15.49%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223450abe63461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223450abe63461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNAZ","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514378305","title":"Transcode Therapeutics, Inc.盘中异动 股价大跌5.56%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514378305?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:46","pubTimestamp":1740753964,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时46分，Transcode Therapeutics, Inc.股票出现波动，股价大幅下跌5.56%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.、Immunitybio, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为512.94%、339.48%、276.30%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.，振幅分别为45.32%、31.14%、29.25%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822460496341d74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822460496341d74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514738591","title":"Transcode Therapeutics, Inc.盘中异动 早盘快速下挫21.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514738591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514738591?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:36","pubTimestamp":1740666978,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时36分，Transcode Therapeutics, Inc.股票出现波动，股价急速下挫21.79%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alector, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为434.17%、92.95%、68.95%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Aurinia Pharmaceuticals Inc，振幅分别为16.59%、15.14%、14.91%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223619abdf6ff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223619abdf6ff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514013879","title":"Transcode Therapeutics, Inc.盘中异动 股价大跌6.05%报6.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514013879?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:58","pubTimestamp":1740495491,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时58分，Transcode Therapeutics, Inc.股票出现波动，股价快速跳水6.05%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Lava Therapeutics N.V.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为978.61%、734.95%、562.63%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为121.95%、46.65%、43.70%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225811a2538d79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225811a2538d79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNAZ","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720932","title":"Transcode Therapeutics, Inc.盘中异动 急速下挫7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513720932?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:43","pubTimestamp":1740408215,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时43分，Transcode Therapeutics, Inc.股票出现波动，股价快速下挫7.12%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为84.61%、50.66%、24.62%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Vaxart, Inc. - Common Stock，振幅分别为100.73%、27.99%、21.42%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242243369890f8db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242243369890f8db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513291478","title":"Transcode Therapeutics, Inc.盘中异动 早盘股价大跌5.98%报8.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513291478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513291478?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:27","pubTimestamp":1740151635,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时27分，Transcode Therapeutics, Inc.股票出现异动，股价大幅下跌5.98%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。此外，TransCode 还在开发一流的 RNA 候选疗法产品组合，旨在克服 RNA 递送方面的挑战，从而打开治疗各种新型基因靶点的通道，这些靶点可能与治疗各种癌症相关。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221232715a24ebdcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221232715a24ebdcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RNAZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512484717","title":"Transcode Therapeutics, Inc.盘中异动 快速下挫5.56%报10.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512484717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512484717?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:41","pubTimestamp":1739983307,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时41分，Transcode Therapeutics, Inc.股票出现异动，股价急速下挫5.56%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为594.07%、245.75%、202.14%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220004147988b4642&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220004147988b4642&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNAZ","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512166055","title":"Transcode Therapeutics, Inc.盘中异动 急速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512166055?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:56","pubTimestamp":1739890612,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时56分，Transcode Therapeutics, Inc.股票出现异动，股价大幅上涨5.19%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。此外，TransCode 还在开发一流的 RNA 候选疗法产品组合，旨在克服 RNA 递送方面的挑战，从而打开治疗各种新型基因靶点的通道，这些靶点可能与治疗各种癌症相关。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225653988a0241&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225653988a0241&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511694865","title":"Transcode Therapeutics, Inc.盘中异动 早盘大幅跳水5.21%报10.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511694865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511694865?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:15","pubTimestamp":1739546102,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时15分，Transcode Therapeutics, Inc.股票出现波动，股价急速下跌5.21%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2333.27%、609.93%、467.29%，振幅较大的相关个股有Moleculin Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cns Pharmaceuticals, Inc.，振幅分别为66.93%、43.67%、40.35%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231503abcf1087&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231503abcf1087&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","RNAZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511525045","title":"Transcode Therapeutics, Inc.盘中异动 早盘股价大跌5.19%报10.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511525045?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:36","pubTimestamp":1739457404,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时36分，Transcode Therapeutics, Inc.股票出现异动，股价大幅跳水5.19%。截至发稿，该股报10.22美元/股，成交量6488股，换手率0.93%，振幅3.34%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。此外，TransCode 还在开发一流的 RNA 候选疗法产品组合，旨在克服 RNA 递送方面的挑战，从而打开治疗各种新型基因靶点的通道，这些靶点可能与治疗各种癌症相关。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322364598842cb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322364598842cb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNAZ","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510470338","title":"Transcode Therapeutics, Inc.盘中异动 早盘股价大涨7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510470338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510470338?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:59","pubTimestamp":1739285975,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时59分，Transcode Therapeutics, Inc.股票出现波动，股价快速拉升7.12%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.29%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2436.32%、682.52%、307.15%，振幅较大的相关个股有Dominari Holdings Inc.、In8Bio, Inc.、Ocean Biomedical, Inc.，振幅分别为45.29%、37.99%、33.04%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211225936abcb0c60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211225936abcb0c60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","RNAZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510886616","title":"Transcode Therapeutics, Inc.盘中异动 快速拉升5.38%报10.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510886616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510886616?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:53","pubTimestamp":1739199222,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时53分，Transcode Therapeutics, Inc.股票出现异动，股价急速上涨5.38%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2203.40%、1391.51%、798.24%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为59.71%、48.38%、39.13%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225342a240a773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225342a240a773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNAZ","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509992272","title":"Transcode Therapeutics, Inc.盘中异动 急速上涨26.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509992272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509992272?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:35","pubTimestamp":1738852522,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时35分，Transcode Therapeutics, Inc.股票出现波动，股价急速拉升26.52%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Immatics N V C/Wts 01/07/2025 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为4169.23%、373.95%、116.76%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Celularity Inc C/Wts 16/07/2026 、Rani Therapeutics Holdings, Inc.，振幅分别为55.65%、27.95%、18.06%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223522987c8f71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223522987c8f71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509282962","title":"Transcode Therapeutics, Inc.盘中异动 股价大涨7.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509282962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509282962?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:31","pubTimestamp":1738765865,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时31分，Transcode Therapeutics, Inc.股票出现波动，股价快速拉升7.95%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.较为活跃，换手率分别为2463.05%、592.55%、570.37%，振幅较大的相关个股有Oragenics Inc.、Novabay Pharmaceuticals, Inc.、Pasithea Therapeutics Corp.，振幅分别为9.75%、8.65%、8.17%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223105abc37d36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223105abc37d36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","BK4139","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509746446","title":"Transcode Therapeutics, Inc.盘中异动 快速下跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509746446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509746446?lang=zh_cn&edition=full","pubTime":"2025-02-05 01:23","pubTimestamp":1738689803,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日01时23分，Transcode Therapeutics, Inc.股票出现波动，股价大幅下挫5.60%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1755.30%、956.84%、568.00%，振幅较大的相关个股有Azitra Inc、Cingulate Inc C/Wts 10/12/2026 、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、57.14%、52.61%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205012324abc248b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205012324abc248b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNAZ","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149718","title":"Transcode Therapeutics, Inc.盘中异动 早盘快速下跌8.07%报6.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149718?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593177,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Transcode Therapeutics, Inc.股票出现波动，股价快速下跌8.07%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为337.02%、261.22%、128.40%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Briacell Therapeutics Corp.，振幅分别为57.05%、33.33%、20.32%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223257abc1072f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223257abc1072f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transcodetherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0859},{"period":"1month","weight":-0.1534},{"period":"3month","weight":-0.6237},{"period":"6month","weight":-0.7964},{"period":"1year","weight":-0.8396},{"period":"ytd","weight":-0.7818}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TransCode Therapeutics, Inc.于2016年1月11日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，率先开发用于高危和晚期癌症的免疫肿瘤学及RNA疗法。其主要候选药物TTX-MC138是一种靶向致癌微小RNA的反义抑制剂，并通过收购Polynoma扩大了研发管线，后者正在开发用于黑色素瘤的研究性癌症疫苗Seviprotimut-L。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.151744},{"month":2,"riseRate":0.4,"avgChangeRate":-0.217151},{"month":3,"riseRate":0.2,"avgChangeRate":-0.176578},{"month":4,"riseRate":0,"avgChangeRate":-0.095649},{"month":5,"riseRate":0.2,"avgChangeRate":0.100121},{"month":6,"riseRate":0.4,"avgChangeRate":-0.168896},{"month":7,"riseRate":0.4,"avgChangeRate":-0.096102},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.195558},{"month":9,"riseRate":0.333333,"avgChangeRate":0.053258},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.14662},{"month":11,"riseRate":0,"avgChangeRate":-0.212761},{"month":12,"riseRate":0.2,"avgChangeRate":-0.139059}],"exchange":"NASDAQ","name":"TransCode Therapeutics  Inc.","nameEN":"TransCode Therapeutics  Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransCode Therapeutics  Inc.(RNAZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TransCode Therapeutics  Inc.(RNAZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TransCode Therapeutics  Inc.,RNAZ,TransCode Therapeutics  Inc.股票,TransCode Therapeutics  Inc.股票老虎,TransCode Therapeutics  Inc.股票老虎国际,TransCode Therapeutics  Inc.行情,TransCode Therapeutics  Inc.股票行情,TransCode Therapeutics  Inc.股价,TransCode Therapeutics  Inc.股市,TransCode Therapeutics  Inc.股票价格,TransCode Therapeutics  Inc.股票交易,TransCode Therapeutics  Inc.股票购买,TransCode Therapeutics  Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransCode Therapeutics  Inc.(RNAZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TransCode Therapeutics  Inc.(RNAZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}